APPLICATION
ANDA064126
TYPE
ANDA
ORIGINAL APPROVAL
1996-07-03
LATEST ACTION
2008-03-31
ROUTE
TOPICAL
DOSAGE FORM
SWAB
MARKETING STATUS
Prescription
Products
ERYTHROMYCINPrescription
ERYTHROMYCIN 2% · SWAB · TOPICAL
Approval history
2008-03-31Labeling · Supplement 9AP
2002-09-16Manufacturing (CMC) · Supplement 6AP
2002-02-20Manufacturing (CMC) · Supplement 3AP
2001-12-06Manufacturing (CMC) · Supplement 4AP
2001-12-06Manufacturing (CMC) · Supplement 5AP
2000-11-17Manufacturing (CMC) · Supplement 2AP
1997-07-11Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.